Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Receptor BioLogix, Inc.
Download detailed PDF Members: Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.
This page has been viewed 350 times since April 2007, the link to the organisation's website has been followed 65 times Recent Search Terms used to find this page: Receptor Biologix Inc. | receptor biologix inc | Receptor Biologix, Inc. | Receptor Biologix, Inc. | Receptor BioLogix Inc. | Receptor Biologix., Inc. | . Search for more companies in South San Francisco Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Receptor BioLogix, Inc. | ||||||||||||||||||||||||||
|